Premium
Stroke thrombolysis in patients taking dabigatran
Author(s) -
Jayathissa S.,
Gommans J.,
Harper P.
Publication year - 2013
Publication title -
internal medicine journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.596
H-Index - 70
eISSN - 1445-5994
pISSN - 1444-0903
DOI - 10.1111/imj.12182
Subject(s) - medicine , dabigatran , thrombolysis , stroke (engine) , medline , intensive care medicine , cardiology , atrial fibrillation , myocardial infarction , warfarin , mechanical engineering , engineering , political science , law
Stroke thrombolysis is becoming a common practice in A ustralian and N ew Z ealand hospitals. There are no established guidelines for thrombolysis of patients who are taking dabigatran, and accurate medication reconciliation may not be possible. Patients with normal activated partial thromboplastin time are unlikely to have clinically significant dabigatran concentration in the blood. For safest outcomes, we suggest incorporating thrombin time assay for acute stroke patients suspected to be taking dabigatran.